Geibel John-P
Department of Surgery, Yale University School of Medicine, BML 265, New Haven, CT 06520, USA.
World J Gastroenterol. 2005 Sep 14;11(34):5259-65. doi: 10.3748/wjg.v11.i34.5259.
Potassium (K+) ions are critical for the activation and catalytic cycle of the gastric H+, K(+)-ATPase, resulting in the secretion of hydrochloric acid into the parietal cell canaliculus. As both symptom, severity and esophageal mucosal damage in gastro-esophageal reflux disease (GERD) are related to the degree of acid exposure, K+ is a logical target for approaches to inhibit acid production. The probable K+ binding site on the gastric H+, K(+)-ATPase has recently been described and studies are elucidating how K+ activates the enzyme. K+ channels in the apical membrane of the parietal cell are implicated in the recycling of K+ and, to date, three potential K+ channels (KCNQ1, Kir2.1 and Kir4.1) have been identified. The channels represent theoretical sites for agents to control acid secretion but it will be difficult to develop selective blockers. An alternative strategy is to prevent K+ from activating gastric H+, K(+)-ATPase; the potassium-competitive acid blocker (P-CAB) class inhibits acid secretion by binding at or near the K+ binding site. Ongoing research is further defining the role of K+ in the functioning of the gastric H+, K(+)-ATPase, as well as determining the clinical utility of agents directed toward this important cation.
钾离子(K+)对于胃H+,K(+)-ATP酶的激活和催化循环至关重要,从而导致盐酸分泌到壁细胞小管中。由于胃食管反流病(GERD)的症状、严重程度和食管黏膜损伤均与酸暴露程度相关,钾离子是抑制酸分泌方法的合理靶点。最近已描述了胃H+,K(+)-ATP酶上可能的钾离子结合位点,并且研究正在阐明钾离子如何激活该酶。壁细胞顶端膜中的钾离子通道与钾离子的循环利用有关,迄今为止,已鉴定出三种潜在的钾离子通道(KCNQ1、Kir2.1和Kir4.1)。这些通道是控制酸分泌药物的理论作用位点,但开发选择性阻滞剂将很困难。另一种策略是阻止钾离子激活胃H+,K(+)-ATP酶;钾离子竞争性酸阻滞剂(P-CAB)类通过在钾离子结合位点或其附近结合来抑制酸分泌。正在进行的研究正在进一步明确钾离子在胃H+,K(+)-ATP酶功能中的作用,以及确定针对这种重要阳离子的药物的临床应用价值。